BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2003
View Archived Issues
CAT, Micromet and Enzon sign crosslicense agreement
Read More
Reduced mortality associated with pexelizumab in acute myocardial infarction
Read More
ALT-711 improves diastolic filling and quality of life in patients with DHF
Read More
Ranolazine equally safe and effective in diabetic and nondiabetic patients with angina
Read More
Good efficacy and safety profiles described for ivabradine and atenolol in stable angina
Read More
Elidel studies reveal patient satisfaction with eczema treatment
Read More
Two new phase I trials investigate Xcytrin plus Taxotere for advanced cancers
Read More
Provenge receives fast track designation
Read More
Phase I trial evaluates safety of AMD-070 for treatment of HIV infection
Read More
Theratechnologies signs agreement for use of ExoPep platform
Read More
Merck claims new S1P1 receptor agonists with potential as immunosuppressants
Read More
New anti-HCV agents in early development at Ribapharm
Read More
Toa Eiyo scientists prepare and test novel glucose- and lipid-lowering agents
Read More
Dual sigma receptor ligands/AChE inhibitors and their use in psychosis, dementia, etc.
Read More
Kyorin patent covers new NK1 antagonists for urinary incontinence and other uses
Read More
Micromet to develop CAT's EpCAM-targeting antibody
Read More
Microbicide UC-781 enters phase I
Read More
Pozen and Xcel sign commercialization agreement for MT-300
Read More
Selective anti-H. pylori agent synthesized in China
Read More
Positive preclinical results indicate utility of AVI-4179 for treatment of SARS
Read More
Promising anti-HIV agent targets HIV-1 envelope protein
Read More
Japanese group identifies new antiangiogenic/antimetastatic MMP inhibitor
Read More
Continued development of QR-337 to be conducted under IND
Read More
Milestone in Vicuron and Novartis peptide deformylase inhibitor collaboration
Read More
Bicyclic androgen receptor antagonists pursued at BMS
Read More
GW-572016, a dual EGFR/ErbB-2 TK inhibitor, discussed in ACS presentation
Read More